Respiratory virus activity remained low in the United States last week, with COVID levels continuing to decline, but ...
Scripps Research scientists engineered stable RSV and hMPV F proteins, overcoming instability challenges to design effective ...
The oral presentation "Novel Ligand-Targeted Immunotherapy for the Treatment of Human Respiratory Syncytial Virus (RSV)" ...
New COVID-19 research uncovers viral behavior insights, driving innovative treatments with Northwestern Medicine's support.
A research article shows that Eradivir's patent-pending antiviral therapeutic called EV25 reduces lung viral loads of advanced-stage influenza in preclinical studies quicker and more effectively than ...
Widespread distribution of nirsevimab to infants with respiratory syncytial virus infection raised concerns about potential ...
Infants are among the most susceptible to respiratory complications from respiratory syncytial virus, or RSV. While they can ...